FIELD : medicine. SUBSTANCE : group of inventions relates to medicine. Capsule containing an inhalable powder composition containing 75 wt.? or more of levodopa, dipalmitoylphosphatidylcholine (DPPC) and salt. Powder is characterised by a working density of less than 100 g/l. Described is a capsule containing an inhalable powder composition containing 75 wt.? or more of levodopa, dipalmitoylphosphatidylcholine (DPPC) and salt, the powder is characterised by a working density of less than about 100 g/l, and wherein the capsule shell contains hydroxypropyl methylcellulose (HPMC) and titanium dioxide. EFFECT : capsule provides the release of a larger amount of powder compared to the amount of powder released from capsules that do not contain titanium dioxide as capsule material. 18 cl, 6 dwg, 26 tbl, 4 ex